Owned by the Association for International Promotion & Study in Tumors (APSIT)
Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells
CD133-positive cells in hepatocellular carcinoma (HCC) exhibit cancer stem cell (CSC)-like properties as well as resistance to chemotherapeutic agents and ionizing radiation; however, their function remains un...